These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorectal imaging in people aged 18 years and over. They are the first guidelines that take into account the introduction of national bowel cancer screening. For the first time, they also incorporate surveillance of patients following resection of either adenomatous or serrated polyps and also post-colorectal cancer resection. They are primarily aimed at healthcare professionals, and aim to address: Which patients should commence surveillance post-polypectomy and post-cancer resection? What is the appropriate surveillance interval? When can surveillance be stopped? two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument provided a methodological framework for the guidelines. The BSG’s guideline development process was used, which is National Institute for Health and Care Excellence (NICE) compliant. two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps The key recommendations are that the high-risk criteria for future colorectal cancer (CRC) following polypectomy comprise either: two or more premalignant polyps including at least one advanced colorectal polyp (defined as a serrated polyp of at least 10 mm in size or containing any grade of dysplasia, or an adenoma of at least 10 mm in size or containing high-grade dysplasia); or five or more premalignant polyps This cohort should undergo a one-off surveillance colonoscopy at 3 years. Post-CRC resection patients should undergo a 1 year clearance colonoscopy, then a surveillance colonoscopy after 3 more years.

中文翻译：

---

英国胃肠病学协会/大不列颠及爱尔兰结肠直肠病协会/英格兰公共卫生协会息肉切除术后和结直肠癌切除术后监测指南


这些共识指南是由英国胃肠病学会 (BSG)、大不列颠及爱尔兰结肠直肠病协会 (ACPGBI) 和英格兰公共卫生 (PHE) 联合委托制定的。它们为 18 岁及以上人群使用监测结肠镜检查和非结肠镜结直肠成像提供了基于证据的框架。它们是第一个考虑引入全国肠癌筛查的指南。他们还首次对腺瘤或锯齿状息肉切除后以及结直肠癌切除后的患者进行监测。它们主要针对医疗保健专业人员，旨在解决：哪些患者应该在息肉切除术和癌症切除术后开始监测？适当的监测间隔是多少？什么时候可以停止监视？两个或多个癌前息肉，包括至少一个晚期结直肠息肉（定义为大小至少 10 毫米或包含任何级别的不典型增生的锯齿状息肉，或大小至少 10 毫米或包含高度不典型增生的腺瘤）；或五个或以上癌前息肉 研究和评估指南评估 (AGREE II) 工具为指南提供了方法框架。使用了 BSG 的指南制定流程，该流程符合国家健康与护理卓越研究所 (NICE) 的要求。 两个或多个癌前息肉，包括至少一个晚期结直肠息肉（定义为大小至少 10 毫米或包含任何级别的不典型增生的锯齿状息肉，或大小至少 10 毫米或包含高度不典型增生的腺瘤）；或五个或以上癌前息肉 主要建议是，息肉切除术后未来结直肠癌 (CRC) 的高风险标准包括： 两个或以上癌前息肉，包括至少一个晚期结直肠息肉（定义为至少 10 个锯齿状息肉）毫米大小或含有任何级别的不典型增生，或腺瘤大小至少为 10 毫米或含有高度不典型增生）；或五个或更多癌前息肉 该队列应在 3 岁时接受一次性结肠镜检查监测。 CRC 切除后患者应接受 1 年的清除结肠镜检查，然后在 3 年后接受监测结肠镜检查。